Becton, Dickinson and Company
Revenue Breakdown
| Fiscal Year | BD Medical | BD Life Sciences | BD Interventional | Corporate and Other |
|---|---|---|---|---|
| FY2016 | $8.65B | $3.83B | — | — |
| FY2017 | $8.11B | $3.99B | — | — |
| FY2018 | $8.62B | $4.33B | $3.04B | — |
| FY2019 | $9.06B | $4.30B | $3.93B | — |
| FY2022 | $8.84B | $5.56B | $4.46B | — |
| FY2023 | $9.50B | $5.13B | $4.74B | — |
| FY2024 | $10.07B | $5.19B | $4.98B | $-67.0M |
| FY2025 | $11.46B | $5.17B | $5.22B | $0 |